Supporting the

Neuroendocrine Cancer Community

Patients and public are important stakeholders in health technology assessment but the level of involvement is low

Jan 20, 2021

Patients and public are important stakeholders in health technology assessment but the level of involvement is low – a call to action.

Health technology assessment (HTA) agencies have an important role in the evaluation and approval of new technologies. They determine their value within a health system so to promote equitable, quality care with available healthcare resources. Many HTA agencies have some mechanism for involving patients in their processes, but there is great variability and an absence of comprehensive, robust practices for involvement. The accelerating pace of medical innovation creates a need to improve the depth and breadth of patient involvement in the HTA process.

Read full article here